Remove sales-marketing white-papers
article thumbnail

Pharma agency babble

World of DTC Marketing

HEY NOW: If you want a great example of why pharma needs to build expertise in-house and rely less on agencies, read the newest white paper from Intouch Group. About the only thing I agree with is their assessment of sales reps. This white paper, which is nothing more than an agency marketing tool is a bad reflection on Intouch.

Pharma 180
article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

KOL Deliverables = KOL Budget

Medical Device Success

First , find out from your network in your market what KOLs cost per hour. White paperWhite papers make great proof source sales collateral. The KOL could help you with one white paper per quarter. it will take several hours to write a white paper. Now you are thinking….it

Doctors 100
article thumbnail

Exceeding Budgets & Falling Short: EVERSANA Leaders Tell Hard Truths About Omnichannel

Eversana Intouch

“Let’s raise the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the ‘right message at the right time’ to drive meaningful results that wouldn’t otherwise be realized by traditional sales and marketing strategies?

article thumbnail

Personalization In Sales Leads To Increased Loyalty and Repeat Business

Integrity Solutions

Mastering the human side of selling is key to sales success, but what does phrase that mean exactly? At its essence, humanizing the sales experience is really about personalization. The desire for a personalization in the sales experience has only grown in recent years. The same holds true across the sales-service continuum.

Sales 107
article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K., The therapy’s sales and promotion works in Japan following the transfer of marketing authorisation will be carried out by the Kite Cell Therapy Business Unit at Gilead Sciences K.K.

article thumbnail

Lilly and ProQR to expand genetic medicine development agreement

Pharmaceutical Technology

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The companies entered the initial agreement in September last year. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Medicine 131